RecruitingNot ApplicableNCT06805669

This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)

Integrating Early Palliative Care in Advanced SARcoma Patients for Enhanced QUALITY of Life: the SARQUALITY Study


Sponsor

Mount Sinai Hospital, Canada

Enrollment

136 participants

Start Date

Mar 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to learn whether early referral to palliative care improves quality of life for patients with advanced sarcoma. Participants enrolled in this study will complete quality of life questionnaires before starting their treatment, and every 6 weeks for 24 weeks.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing whether involving a palliative care team early — at the same time as standard cancer treatment — improves the quality of life and emotional wellbeing of people newly diagnosed with advanced or metastatic soft tissue sarcoma (a type of cancer that starts in muscles, fat, or other soft tissues). **You may be eligible if...** - You are 18 or older - You have been confirmed by biopsy to have advanced sarcoma that cannot be cured with surgery, or that has spread - You have not yet received chemotherapy or other systemic treatment for advanced disease - You are well enough to carry out some daily activities (ECOG status 0–2) - You have a life expectancy of more than 6 months - You are able and willing to complete questionnaires **You may NOT be eligible if...** - You have cognitive impairment that would prevent you from giving consent or answering questionnaires - You already need urgent palliative care support or are already seeing a palliative care doctor - You have an active psychiatric disorder or substance abuse problem - You are not able to read English well enough to complete the questionnaires Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREarly referral to palliative care

Participant will be referred to palliative care at start of systemic treatment

OTHERStandard Treatment

Participants will be referred to palliative care upon appearance of uncontrollable symptoms.


Locations(1)

Mount Sinai Hospital

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06805669


Related Trials